Morepen Laboratories Limited (MOREPENLAB.BO)
INR 83.77
(-0.35%)
INR 83.77
(-0.35%)
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2023 | 33.64 Million INR | 260.36% |
| 2022 | 9.33 Million INR | -29.34% |
| 2021 | 13.21 Million INR | 59.5% |
| 2020 | 8.28 Million INR | -10.42% |
| 2019 | 9.24 Million INR | -49.45% |
| 2018 | 18.29 Million INR | -37.94% |
| 2017 | 29.47 Million INR | 113.05% |
| 2016 | 13.83 Million INR | -97.29% |
| 2015 | 510.61 Million INR | -18.0% |
| 2014 | 622.68 Million INR | -16.73% |
| 2013 | 747.8 Million INR | -20.99% |
| 2012 | 946.5 Million INR | -16.89% |
| 2011 | 1.13 Billion INR | -11.5% |
| 2010 | 1.28 Billion INR | -7.91% |
| 2009 | 1.39 Billion INR | -50.17% |
| 2008 | 2.8 Billion INR | -4.06% |
| 2007 | 2.92 Billion INR | -41.35% |
| 2006 | 4.98 Billion INR | 0.0% |
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2024 Q1 | - INR | -100.0% |
| 2023 Q4 | 33.64 Million INR | 0.0% |
| 2023 Q1 | - INR | -100.0% |
| 2023 Q2 | 12.67 Million INR | 0.0% |
| 2023 Q3 | - INR | -100.0% |
| 2023 FY | 33.64 Million INR | 260.36% |
| 2022 FY | 9.33 Million INR | -29.34% |
| 2022 Q3 | - INR | -100.0% |
| 2022 Q4 | 9.33 Million INR | 0.0% |
| 2022 Q1 | - INR | -100.0% |
| 2022 Q2 | 11.4 Million INR | 0.0% |
| 2021 Q1 | - INR | -100.0% |
| 2021 FY | 13.21 Million INR | 59.5% |
| 2021 Q2 | 6.48 Million INR | 0.0% |
| 2021 Q4 | 13.21 Million INR | 0.0% |
| 2021 Q3 | - INR | -100.0% |
| 2020 FY | 8.28 Million INR | -10.42% |
| 2020 Q2 | 6.94 Million INR | 0.0% |
| 2020 Q4 | 8.28 Million INR | 0.0% |
| 2020 Q3 | - INR | -100.0% |
| 2020 Q1 | - INR | -100.0% |
| 2019 Q2 | 15.57 Million INR | 0.0% |
| 2019 Q4 | 9.24 Million INR | 0.0% |
| 2019 FY | 9.24 Million INR | -49.45% |
| 2019 Q1 | - INR | -100.0% |
| 2019 Q3 | - INR | -100.0% |
| 2018 Q4 | 18.29 Million INR | 0.0% |
| 2018 FY | 18.29 Million INR | -37.94% |
| 2018 Q3 | - INR | -100.0% |
| 2018 Q2 | 24.71 Million INR | 0.0% |
| 2018 Q1 | - INR | -100.0% |
| 2017 Q1 | - INR | 0.0% |
| 2017 FY | 29.47 Million INR | 113.05% |
| 2017 Q4 | 29.47 Million INR | 0.0% |
| 2016 FY | 13.83 Million INR | -97.29% |
| 2015 FY | 510.61 Million INR | -18.0% |
| 2014 FY | 622.68 Million INR | -16.73% |
| 2013 FY | 747.8 Million INR | -20.99% |
| 2012 FY | 946.5 Million INR | -16.89% |
| 2011 FY | 1.13 Billion INR | -11.5% |
| 2010 FY | 1.28 Billion INR | -7.91% |
| 2009 FY | 1.39 Billion INR | -50.17% |
| 2008 FY | 2.8 Billion INR | -4.06% |
| 2007 FY | 2.92 Billion INR | -41.35% |
| 2006 FY | 4.98 Billion INR | 0.0% |
| Name | Long Term Debt | Long Term Debt Difference |
|---|---|---|
| Ajanta Pharma Limited | 235.2 Million INR | 85.697% |
| Amrutanjan Health Care Limited | 13.96 Million INR | -140.836% |
| Sigachi Industries Limited | 265.79 Million INR | 87.344% |
| Bal Pharma Limited | 363.82 Million INR | 90.754% |
| Ind-Swift Laboratories Limited | 111.62 Million INR | 69.864% |
| Medico Remedies Limited | 8.67 Million INR | -287.915% |
| Lasa Supergenerics Limited | - INR | -Infinity% |
| Venus Remedies Limited | 386.8 Million INR | 91.303% |
| Sun Pharma Advanced Research Company Limited | 106.6 Million INR | 68.443% |
| Alpa Laboratories Limited | - INR | -Infinity% |
| Nectar Lifesciences Limited | 1.4 Billion INR | 97.602% |
| Shilpa Medicare Limited | 5.6 Billion INR | 99.399% |
| Aarti Drugs Limited | 2.75 Billion INR | 98.778% |
| Lupin Limited | 1.55 Billion INR | 97.834% |
| Aurobindo Pharma Limited | 21.34 Billion INR | 99.842% |
| Zydus Lifesciences Limited | 251 Million INR | 86.598% |
| Windlas Biotech Limited | 20.18 Million INR | -66.7% |
| Suven Life Sciences Limited | - INR | -Infinity% |
| Eris Lifesciences Limited | 6.54 Billion INR | 99.486% |
| Valiant Laboratories Limited | 746.63 Million INR | 95.494% |
| J. B. Chemicals & Pharmaceuticals Limited | 236.4 Million INR | 85.77% |
| Solara Active Pharma Sciences Limited | 1.05 Billion INR | 96.821% |
| Ipca Laboratories Limited | 5.8 Billion INR | 99.42% |
| Bliss GVS Pharma Limited | 355.92 Million INR | 90.548% |
| Achyut Healthcare Limited | - INR | -Infinity% |
| Sun Pharmaceutical Industries Limited | 13.3 Million INR | -152.932% |
| Bajaj HealthCare Limited | 650.34 Million INR | 94.827% |
| RPG Life Sciences Limited | -30.3 Million INR | 211.023% |
| Mankind Pharma Limited | 248.67 Million INR | 86.472% |
| Laurus Labs Limited | 8.6 Billion INR | 99.609% |
| Piramal Pharma Limited | 24.83 Billion INR | 99.865% |
| Syncom Formulations (India) Limited | -1.21 Million INR | 2859.639% |
| Torrent Pharmaceuticals Limited | 16.04 Billion INR | 99.79% |
| Alembic Pharmaceuticals Limited | 628.8 Million INR | 94.65% |
| Glenmark Pharmaceuticals Limited | 1.51 Billion INR | 97.782% |
| Unichem Laboratories Limited | 382.22 Million INR | 91.199% |
| Sequent Scientific Limited | 1.42 Billion INR | 97.643% |
| Novartis India Limited | 50.7 Million INR | 33.649% |
| Wanbury Limited | 820 Million INR | 95.898% |
| Suven Pharmaceuticals Limited | 212.35 Million INR | 84.159% |
| Wockhardt Limited | 8.91 Billion INR | 99.622% |
| Themis Medicare Limited | 267.74 Million INR | 87.436% |
| Jagsonpal Pharmaceuticals Limited | 75.57 Million INR | 55.485% |
| Jubilant Pharmova Limited | 31.67 Billion INR | 99.894% |
| Glenmark Life Sciences Limited | 147.61 Million INR | 77.21% |
| Dr. Reddy's Laboratories Limited | 5.99 Billion INR | 99.438% |
| Divi's Laboratories Limited | 20 Million INR | -68.2% |
| NATCO Pharma Limited | 53 Million INR | 36.528% |
| Gufic Biosciences Limited | 1.53 Billion INR | 97.815% |
| IOL Chemicals and Pharmaceuticals Limited | - INR | -Infinity% |
| Ind-Swift Limited | 10.09 Billion INR | 99.667% |
| Procter & Gamble Health Limited | 68.8 Million INR | 51.105% |
| FDC Limited | 2.46 Million INR | -1264.152% |
| Krebs Biochemicals & Industries Limited | 1.83 Billion INR | 98.167% |
| Granules India Limited | 689.71 Million INR | 95.123% |
| Medicamen Biotech Limited | 12.55 Million INR | -167.941% |
| Alkem Laboratories Limited | 400 Million INR | 91.59% |
| AstraZeneca Pharma India Limited | 27.83 Million INR | -20.851% |
| Biofil Chemicals and Pharmaceuticals Limited | - INR | -Infinity% |
| Brooks Laboratories Limited | 3.56 Million INR | -843.619% |
| Megasoft Limited | 1.35 Billion INR | 97.521% |
| ZIM Laboratories Limited | 356 Million INR | 90.551% |
| Strides Pharma Science Limited | 6.71 Billion INR | 99.499% |
| Neuland Laboratories Limited | 449.2 Million INR | 92.511% |
| Hikal Limited | 4.22 Billion INR | 99.204% |
| Indoco Remedies Limited | 3.51 Billion INR | 99.044% |
| Aarti Pharmalabs Limited | 400 Thousand INR | -8310.0% |
| Kilitch Drugs (India) Limited | - INR | -Infinity% |
| Mangalam Drugs & Organics Limited | 133.54 Million INR | 74.809% |
| Hester Biosciences Limited | 1.81 Billion INR | 98.149% |